WilmerHale client PerkinElmer, Inc. (NYSE: PKI), a global leader focused on improving the health and safety of people and the environment, today announced that it has signed a definitive agreement to acquire Caliper Life Sciences, Inc. (NASDAQ: CALP), a Hopkinton, Massachusetts-based leader in imaging and detection solutions for life sciences research, diagnostics and environmental markets, for a net purchase price of approximately $600 million in cash.
The transaction enhances PerkinElmer's global leadership position in molecular imaging and detection for human and environmental health, creating the opportunity to significantly expand global delivery of compelling customer solutions in a broad range of high-growth end markets, while the combined R&D expertise and intellectual property of PerkinElmer and Caliper Life Sciences will accelerate innovation in the field.
Partners Hal Leibowitz and Graham Robinson led the WilmerHale team representing PerkinElmer which also included Counsel Rebecca Chang and Associate Stephanie Singer on corporate/M&A aspects; Partners John Sigel and Erika Robinson on corporate finance; Partner Rob Burke on tax; and Partner Amy Null on benefits.